Mass General’s Marian DiFiglia, PhD, is working to advance research on the rare genetic mutation that affects her grandson.
Bone health specialists typically spend their time trying to figure how to slow or stop the bone loss that leads to osteoporosis. What if they could find a new way to stimulate the growth of new bone tissue instead?
Rare diseases can be very complex to treat due to lack of understanding, little to no options for treatment and limited funding. But it is for these reasons that raising awareness and supporting research and funding for rare diseases is so important. In honor of Rare Disease Day this year, we are highlighting a rare disease called neuromyelitis optica (NMO).
Massachusetts General Hospital’s talented and dedicated researchers are working to push the boundaries of science and medicine every day. In this series we highlight a few individuals who have recently received awards or honors for their achievements: M. Amin Arnaout, MD, chief emeritus of the Division of Nephrology and director of the Leukocyte Biology and […]
Earlier this week, the Mass General Neurological Clinical Research Center (NCRI)’s NeuroBANK™ won Bio-IT World‘s Best Practice award in the Personalized & Translational Medicine category. What is the NeuroBANK, and how is it helping to accelerate the discovery, development, and delivery of future treatments for rare diseases including amyotrophic lateral sclerosis (ALS)? Filling a Need […]
While it may not have been called rare disease research by name, Massachusetts General Hospital has been identifying and tracking rare diseases for more than a century, says Florian Eichler, MD, Director of the Center for Rare Neurological Diseases in the Department of Neurology. In recent years, advances made by the Human Genome Project and […]
Mass General researchers recently published an article detailing a new treatment for a dangerous swelling condition called Hereditary angioedema.
What is the fastest way to develop new treatments for patients with rare diseases? In a word, teamwork. That was the consensus that emerged from an hour-long panel discussion on rare disease research hosted by the Division of Clinical Research at Massachusetts General Hospital last month. “By their very definition, rare diseases have limited resources and we all […]